Relationship between acute rejection and cyclosporine or mycophenolic acid levels in Japanese heart transplantation

Circulation Journal

Volumn 71, Issue 3, 2007, Pages 289-293

  Wada, Kyoichi ^a   Takada, Mitsutaka ^b   Ueda, Takashi ^c   Ochi, Hiroyuki ^a   Kotake, Takeshi ^a   Morishita, Hideki ^a   Hanatani, Akihisa ^a   Nakatani, Takeshi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Cyclosporine; Japanese heart transplantation; Mycophenolate mofetil; Serum concentration time curve

Indexed keywords

CYCLOSPORIN; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; OKT 3; PREDNISOLONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOPSY; CASE REPORT; COMBINATION CHEMOTHERAPY; CONGESTIVE CARDIOMYOPATHY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; JAPANESE; LEUKOCYTE COUNT; MALE; SIDE EFFECT;

ADULT; AREA UNDER CURVE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; JAPAN; MALE; MYCOPHENOLIC ACID; PREDICTIVE VALUE OF TESTS; PREDNISOLONE;

EID: 33947151429     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.289     Document Type: Article

References (24)

1. Nakatani T. The present status of heart transplantation in Japanese. Transplant Now 2005; 18: 287-293.
2. Kitamura S, Kurosawa H, Kondo T, Simizu N, Matuda H, Wada H. Heart and lung transplantation protocols. First ed, Medical View Company, Japan, 2003.
3. Belitsky P, Dunn S, Johnston A, Levy G. Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients. Clin Pharmacokinet 2000; 39: 117-125.
4. Mahalati K, Belitsky P, Sketris I, West K, Panek R. Neoral monitoring by simplified sparse sampling area under the concentration-time curve: Its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation. Transplantation 1999; 68: 55-62.
5. Belitsky P, Levy GA, Johnston A. Neoral absorption profiling: An evolution in effectiveness. Transplant Proc 2000; 32: 45S-52S.
6. Cantarovich M, Elstein E, de Varennes B, Barkun JS. Clinical benefit of Neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients. Transplantation 1999; 68: 1839-1842.
7. Armstrong VW, Oellerich M. New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine. Clin Biochem 2001; 34: 9-16.
8. Cooney GF, Johnston A. Neoral C-2 monitoring in cardiac transplant patients. Transplant Proc 2001; 33: 1572-1575.
9. Cantarovich M, Besner JG, Barkun JS, Elstein E, Loertscher R. Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy. Clin Transplant 1998; 12: 243-249.
10. Delgado DH, Rao V, Hamel J, Miriuka S, Cusimano RJ, Ross HJ. Monitoring of cyclosporine 2-hour post-dose levels in heart transplantation: Improvement in clinical outcomes. J Heart Lung Transplant 2005; 24: 1343-1346.
11. Chou NK, Chen RJ, Ko WJ, Lin HL, Yu SY, Chen YS, et al. Cyclosporine C2 monitoring is superior to C0 in predicting acute cellular rejection in heart transplant recipients in Taiwan. Transplant Proc 2004; 36: 2393-2395.
12. Shaw LM, Nicholls A, Hale M, Armstrong VW, Oellerich M, Yatscoff R, et al. Therapeutic monitoring of mycophenolic acid: A consensus panel report. Clin Biochem 1998; 31: 317-322.
13. DeNofrio D, Loh E, Kao A, Korecka M, Pickering FW, Craig KA, et al. Mycophenolic acid concentrations are associated with cardiac allograft rejection. J Heart Lung Transplant 2000; 19: 1071-1076.
14. Shaw LM, Korecka M, Aradhye S, Grossman R, Bayer L, Innes C, et al. Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable. J Clin Pharmacol 2000; 40: 624-633.
15. Barten MJ, Rahmel A, Garbade J, Richter M, Bittner HB, Dhein S, et al. C0h/C2h monitoring of the pharmacodynamics of cyclosporin plus mycophenolate mofetil in human heart transplant recipients. Transplant Proc 2005; 37: 1360-1361.
16. Hale MD, Nicholls AJ, Bullingham RE, Hene R, Hoitsma A, Squifflet JP, et al. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clin Pharmacol Ther 1998; 64: 672-683.
17. Takahashi K, Ochiai T, Uchida K, Yasumura T, Ishibashi M, Suzuki S, et al. Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients: RS-61443 Investigation Committee Japan. Transplant Proc 1995; 27: 1421-1424.
18. Shaw LM, Korecka M, DeNofrio D, Brayman KL. Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients. Clin Biochem 2001; 34: 17-22.
19. Shaw LM, Kaplan B, DeNofrio D, Korecka M, Brayman KL. Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation. Ther Drug Monit 2000; 22: 14-19.
20. Tsina I, Kaloostian M, Lee R, Tarnowski T, Wong B. High-perfomance liquid chromatographic method for the determination of mycophenolate mofetil in human plasma. J Chromatogr B Biomed Appl 1996; 68: 347-353.
21. Monta O, Matsumiya G, Fukushima N, Miyamoto Y, Sawa Y, Koseki M, et al. Mechanical ventricular assist system required for sustained severe cardiac dysfunction secondary to peripartum cardiomyopathy. Circ J 2005; 69: 362-364.
22. Wada K, Takada M, Ueda T, Ochi H, Morishita H, Hanatani A, et al. Pharmacokinetic study and limited sampling strategy of cyclosporine in Japanese heart transplant recipients. Circ J 2006; 70: 1307-1311.
23. Cantarovich M, Giannetti N, Cecere R. Impact of cyclosporine 2-h level and Mycophenolate mofetil dose on clinical outcomes in de novo heart transplant patients receiving anti-thymocyte globulin induction. Clin Transplant 2003; 17: 144-150.
24. Pawinski T, Hale M, Korecka M, Fitzsimmons WE, Shaw LM. Limited sampling strategy for the estimation of Mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus. Clin Chem 2002; 48: 1497-1504.